Insmed (INSM) Insider Trading & Ownership $144.65 -0.10 (-0.07%) As of 03:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Insmed (NASDAQ:INSM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.00%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$201.69KNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$121.35M Get INSM Insider Trade Alerts Want to know when executives and insiders are buying or selling Insmed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSM Insider Buying and Selling by Quarter Insmed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2025Melvin Md SharokyDirectorSell10,000$145.39$1,453,900.00 9/12/2025Orlov S Nicole SchaefferInsiderSell76,520$145.45$11,129,834.00 9/2/2025Michael Alexander SmithInsiderSell24,272$143.89$3,492,498.08 8/20/2025Melvin Md SharokyDirectorSell10,000$129.50$1,295,000.00 8/19/2025Roger AdsettCOOSell25,000$127.58$3,189,500.00 8/18/2025William LewisCEOSell6,865$128.40$881,466.00 8/8/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$109.55$1,001 - $15,0007/21/2025Sara BonsteinCFOSell58,400$102.67$5,995,928.00 7/15/2025Michael Alexander SmithInsiderSell933$102.51$95,641.83 7/15/2025William LewisCEOSell6,830$102.37$699,187.10 7/11/2025Michael Alexander SmithInsiderSell748$96.41$72,114.68 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/7/2025Sara BonsteinCFOSell57,764$95.86$5,537,257.04 7/7/2025Gilbert Ray Cisneros, Jr.U.S. Congress Member (D-CA)Sell$96.95$1,001 - $15,0006/23/2025Sara BonsteinCFOSell57,765$101.78$5,879,321.70 6/16/2025William LewisCEOSell129,805$100.39$13,031,123.95 6/16/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$101.59$1,001 - $15,0006/11/2025Orlov S Nicole SchaefferInsiderSell99,172$93.42$9,264,648.24 6/10/2025Sara BonsteinCFOSell57,766$89.12$5,148,105.92 6/5/2025Michael Alexander SmithInsiderSell1,879$73.50$138,106.50 6/4/2025David W J McgirrDirectorSell3,000$73.27$219,810.00 6/3/2025David W J McgirrDirectorSell3,250$71.30$231,725.00 6/3/2025Martina M.D. FlammerInsiderSell1,686$71.50$120,549.00 6/3/2025Michael Alexander SmithInsiderSell1,448$71.50$103,532.00 6/3/2025Orlov S Nicole SchaefferInsiderSell1,642$71.50$117,403.00 6/3/2025Roger AdsettCOOSell1,860$71.50$132,990.00 6/3/2025Sara BonsteinCFOSell1,579$71.50$112,898.50 6/3/2025William LewisCEOSell5,472$71.50$391,248.00 6/2/2025William LewisCEOSell6,830$71.31$487,047.30 5/21/2025Clarissa DesjardinsDirectorBuy1,130$66.35$74,975.50 5/20/2025Clarissa DesjardinsDirectorBuy1,895$66.87$126,718.65 5/20/2025William LewisCEOSell21,057$67.65$1,424,506.05 5/20/2025William LewisCEOSell6,830$67.72$462,527.60 5/16/2025Martina M.D. FlammerInsiderSell1,799$67.53$121,486.47 5/15/2025Martina M.D. FlammerInsiderSell9,925$65.47$649,789.75 5/14/2025Martina M.D. FlammerInsiderSell1,744$65.61$114,423.84 5/14/2025Michael Alexander SmithInsiderSell409$65.61$26,834.49 5/14/2025Orlov S Nicole SchaefferInsiderSell1,236$65.61$81,093.96 5/14/2025Roger AdsettCOOSell1,925$65.61$126,299.25 5/14/2025Sara BonsteinCFOSell1,634$65.61$107,206.74 5/14/2025William LewisCEOSell3,771$65.61$247,415.31 5/13/2025Martina M.D. FlammerInsiderSell8,408$67.81$570,146.48 5/13/2025Michael Alexander SmithInsiderSell4,407$67.81$298,838.67 5/13/2025Orlov S Nicole SchaefferInsiderSell4,999$67.81$338,982.19 5/13/2025Roger AdsettCOOSell7,482$67.81$507,354.42 5/13/2025Sara BonsteinCFOSell8,870$67.81$601,474.70 5/13/2025William LewisCEOSell17,442$66.97$1,168,090.74 5/1/2025William LewisCEOSell6,830$72.57$495,653.10 4/15/2025William LewisCEOSell6,830$70.16$479,192.80 4/9/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$67.55$1,001 - $15,0003/17/2025William LewisCEOSell18,750$77.03$1,444,312.50 3/3/2025William LewisCEOSell18,750$77.79$1,458,562.50 2/18/2025Sara BonsteinCFOSell18,322$80.31$1,471,439.82 2/18/2025William LewisCEOSell18,750$81.03$1,519,312.50 2/11/2025Sara BonsteinCFOSell13,302$80.00$1,064,160.00 2/10/2025Martina M.D. FlammerInsiderSell37,828$78.61$2,973,659.08 2/10/2025Roger AdsettCOOSell42,975$78.61$3,378,264.75 2/6/2025Martina M.D. FlammerInsiderSell33,055$80.90$2,674,149.50 2/6/2025Roger AdsettCOOSell45,605$80.90$3,689,444.50 2/6/2025Sara BonsteinCFOSell28,390$80.90$2,296,751.00 2/6/2025William LewisCEOSell79,350$80.90$6,419,415.00 2/3/2025William LewisCEOSell18,750$77.94$1,461,375.00 1/30/2025Orlov S Nicole SchaefferInsiderSell91,140$80.00$7,291,200.00 1/15/2025William LewisCEOSell31,805$70.18$2,232,074.90 1/14/2025Martina M.D. FlammerInsiderSell1,384$68.72$95,108.48 1/14/2025Roger AdsettCOOSell1,457$68.72$100,125.04 1/10/2025Martina M.D. FlammerInsiderSell6,172$63.64$392,786.08 1/10/2025Roger AdsettCOOSell4,902$63.68$312,159.36 1/10/2025Sara BonsteinCFOSell1,066$63.72$67,925.52 1/10/2025William LewisCEOSell2,978$63.36$188,686.08 1/7/2025Martina M.D. FlammerInsiderSell3,344$65.91$220,403.04 1/7/2025Roger AdsettCOOSell2,444$65.95$161,181.80 1/7/2025Sara BonsteinCFOSell3,470$65.70$227,979.00 1/7/2025William LewisCEOSell8,218$66.02$542,552.36 1/2/2025William LewisCEOSell18,750$69.84$1,309,500.00 12/19/2024William LewisCEOSell18,750$69.91$1,310,812.50 (Data available from 1/1/2013 forward) INSM Insider Trading Activity - Frequently Asked Questions Who is on Insmed's Insider Roster? The list of insiders at Insmed includes Clarissa Desjardins, David W J Mcgirr, John Drayton Wise, Martina M.D. Flammer, Melvin Md Sharoky, Michael Alexander Smith, Orlov S Nicole Schaeffer, Roger Adsett, Sara Bonstein, and William Lewis. Learn more on insiders at INSM. What percentage of Insmed stock is owned by insiders? 3.00% of Insmed stock is owned by insiders. Learn more on INSM's insider holdings. Which Insmed insiders have been buying company stock? The following insider purchased INSM shares in the last 24 months: Clarissa Desjardins ($201,694.15). How much insider buying is happening at Insmed? Insiders have purchased a total of 3,025 INSM shares in the last 24 months for a total of $201,694.15 bought. Which Insmed insiders have been selling company stock? The following insiders have sold INSM shares in the last 24 months: David W J Mcgirr ($451,535.00), John Drayton Wise ($1,194,190.95), Martina M.D. Flammer ($11,087,768.05), Melvin Md Sharoky ($2,748,900.00), Michael Alexander Smith ($6,386,393.68), Orlov S Nicole Schaeffer ($30,909,773.89), Roger Adsett ($12,149,097.82), Sara Bonstein ($40,346,588.56), and William Lewis ($42,450,503.79). How much insider selling is happening at Insmed? Insiders have sold a total of 1,963,516 Insmed shares in the last 24 months for a total of $147,724,751.74 sold. Which members of congress are trading Insmed? Josh Gottheimer (D-NJ) has bought shares of Insmed in the last year totaling $8,000. Gilbert Ray Cisneros, Jr. (D-CA) and Josh Gottheimer (D-NJ) have sold shares totaling $24,000. Insmed Key ExecutivesMr. William H. Lewis J.D. (Age 50)Pres, CEO & Chairman Mr. Paolo Tombesi (Age 55)Chief Financial Officer Ms. Christine A. Pellizzari J.D. (Age 51)Chief Legal Officer & Corp. Sec. Mr. Roger Adsett (Age 50)Chief Commercial Officer 4 recent tradesDr. Paul D. Streck (Age 55)Advisor More Insider Trading Tools from MarketBeat Related Companies Sanofi Insider Buying GSK Insider Buying Takeda Pharmaceutical Insider Buying argenex Insider Buying BeOne Medicines Insider Buying BioNTech Insider Buying Teva Pharmaceutical Industries Insider Buying Genmab A/S Insider Buying Summit Therapeutics Insider Buying Viatris Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NASDAQ:INSM) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.